ANGLE plc (LON:AGL – Get Rating) insider Andrew D. Newland bought 125,000 shares of the company’s stock in a transaction on Tuesday, July 19th. The shares were bought at an average cost of GBX 80 ($0.96) per share, for a total transaction of £100,000 ($119,545.73).
ANGLE Stock Performance
Shares of AGL opened at GBX 72.50 ($0.87) on Wednesday. ANGLE plc has a 12 month low of GBX 71.70 ($0.86) and a 12 month high of GBX 163.75 ($1.96). The stock has a fifty day moving average price of GBX 107.26 and a 200-day moving average price of GBX 103.81. The company has a current ratio of 8.01, a quick ratio of 7.54 and a debt-to-equity ratio of 5.80. The firm has a market cap of £170.59 million and a PE ratio of -10.82.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 195 ($2.33) target price on shares of ANGLE in a research report on Monday, May 23rd.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products worldwide. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in cancer patient blood; and HyCEAD multiplex analysis system used as the downstream analysis tool in the ovarian cancer clinical application.
Featured Articles
- Ford Races Higher: Has The Stock Finally Bottomed?
- A Dose of AbbVie Stock Can Help Your Bear Market Portfolio
- PayPal Stock is Attempting to Put in the Floor
- These Consumer Stocks Will Thrive And Here’s Why
- High-Yield Dividend Hasbro May Have Hit Bottom
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.